Hostname: page-component-745bb68f8f-grxwn Total loading time: 0 Render date: 2025-01-11T23:35:55.117Z Has data issue: false hasContentIssue false
  • English
  • Français

Out-of-Pocket Spending and Financial Equity in the Access to Medicines in Latin America: Trends and Challenges: 2010-2020

Published online by Cambridge University Press:  29 December 2023

Rafael Cortez ,
Andre Medici  and
Rucheta Singh
Rafael Cortez
Affiliation:
UNIVERSIDAD DEL PACIFICO, LIMA, PERÚ
Andre Medici
Affiliation:
UNITED STATES HEALTH ALLIANCE (USAHA), WASHINGTON, DC, USA
Rucheta Singh
Affiliation:
WORLD BANK, WASHINGTON, DC, USA
Get access Rights & Permissions [Opens in a new window]

Abstract

There is evidence of persistent inequalities in household financial protection of health and drugs spending in Latin America. Despite the expansion of coverage, strong inequalities persist in access to health and family spending on drugs in the region. Out-of-pocket spending in medicines is regressive in greater need for affordable medicines.

Keywords

DrugsPricesOut-of-Pocket ExpendituresEquityAccessTotal Health Expenditures
Type
Symposium Articles
Information
Journal of Law, Medicine & Ethics , Volume 51 , Issue S1: Rethinking Pharmaceutical Policies in Latin America and the Caribbean , Fall 2023 , pp. 17 - 38
Copyright
© 2023 The Author(s)

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Castaño, R., Arbelaez, J., Gedion, U., and Morales, L.G., “Equitable Financing, Out-of-Pocket Payments and the Role of Health Care Reform in Colombia,” Health Policy and Planning 17, Suppl. 1 (2002): 5–11; World Health Organization, “Financing of Health Care from Households’ Out-of-Pocket Payments, Voluntary Payment Schemes and External Resources,” Health at a Glance: Latin America and the Caribbean 2020 (2020).CrossRefGoogle ScholarPubMed
Sirag, A. and Norashidah, M.N., “Out-of-Pocket Health Expenditure and Poverty: Evidence from a Dynamic Panel Threshold Analysis,” Healthcare 9, no. 5 (2021): at 536.CrossRefGoogle ScholarPubMed
World Health Organization, “Financing of Health Care from Households’ Out-of-Pocket Payments, Voluntary Payment Schemes and External Resources,” Health at a Glance: Latin America and the Caribbean 2020 (2020).Google Scholar
Id. Google Scholar
World Health Organization, World Health Statistics 2023: Monitoring Health for the SDGs, Sustainable Development Goals (2023).Google Scholar
Id. Google Scholar
Id. Google Scholar
OECD, Health Expenditure and Financing, “Health Expenditure Indicators,” available at <https://www.oecd.org/health/health-expenditure.htm> (last visited October 2, 2023).+(last+visited+October+2,+2023).>Google Scholar
Id. Google Scholar
Id. Google Scholar
World Bank data, April 2023, available at < https://data.worldbank.org/indicator/SH.XPD.OOPC.CH.ZS?locations=ZJ-1W> (last visited October 2, 2023).+(last+visited+October+2,+2023).>Google Scholar
Mougenot, B. and Herrera-Añazco, P., “A Bibliometric Analysis of Literature on the Out-of-Pocket Expense in Health in Latin America,” Revista Del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo 15, no. 2 (2022): 241–246.Google Scholar
D. Maceira and A. Jiménez, El gasto de bolsillo en salud como indicador clave de equidad y calidad sistémica en Argentina (2022).Google Scholar
Garcia-Diaz, R., “Effective Access to Health Care in Mexico,” BMC Health Services Research 22, no. 1 (2022).CrossRefGoogle ScholarPubMed
Sáenz-Vela, H.M. and Guzmán-Giraldo, Á.M., “Determinants of Household Health Spending in Mexico,” Problemas Del Desarrollo 52, no. 205 (2021): 3–25.Google Scholar
Rivera-Almaraz, A., Manrique-Espinoza, B., Chatterji, S., Naidoo, N., Kowal, P., and Salinas-Rodríguez, A., “Longitudinal Associations of Multimorbidity, Disability and Out-of-Pocket Health Expenditures in Households with Older Adults in Mexico: The Study on Global Ageing and Adult Health (SAGE),” Disability and Health Journal, 12, no. 4 (2019): 665–672.Google Scholar
Nava-Bolaños, I., “Catastrophic Health Expenditures and Households with Older Adults in Mexico,” Papeles de Población 25, no. 99 (2019): 113–142.Google Scholar
Nievas, C.M., Gandini, J.B., and Tapia, A.B., “Desigualdades en el acceso a medicamentos y gasto de bolsillo, realidades del subsistema público de salud en el interior argentino,” Revista de La Facultad de Ciencias Médicas de Córdoba 78, no. 2 (2021): 147–152.Google Scholar
Giménez, E., Caballero, R., Peralta, N., and Araujo, J.M., “Análisis del gasto de bolsillo ante la enfermedad de personas de 60 y más años según su condición de pobreza en Paraguay,” Revista de Salúd Pública Del Paraguay 9, no. 2 (2019).Google Scholar
See Sáenz-Vela and Guzmán-Giraldo, supra note 15.Google Scholar
See Maceira and Jiménez, supra note 13.Google Scholar
Castillo-Laborde, C. and Villalobos Dintrans, P., “Caracterización del gasto de bolsillo en salud en Chile: una mirada a dos sistemas de protección,” Revista Médica de Chile (2013).CrossRefGoogle Scholar
Alvis-Zakzuk, J., Marrugo-Arnedo, C., N.Alvis-Zakzuk, J., de la Rosa, F.G., Florez-Tanus, A., Moreno-Ruiz, D., and Alvis-Guzmán, N., “Out-of-Pocket Catastrophic Health Expenditure in Households of Cartagena, Colombia,” Revista de Salud Pública 20, no. 5 (2018): 591–598.CrossRefGoogle ScholarPubMed
OECD, “Pharmaceutical Spending,” available at <https://data.oecd.org/healthres/pharmaceutical-spending.htm> (last visited September 1, 2023); Mousnad, M.A., Shafie, A.A., and Ibrahim, M.I., “Systematic Review of Factors Affecting Pharmaceutical Expenditures,” Health Policy 116, nos. 2-3 (2014): 137–46.Google ScholarPubMed
World Bank data, supra note 11.Google Scholar
Ministerio de Salud del Perú, Política nacional de medicamentos, R.M. 1240–2004/MINSA December 24, 2004.Google Scholar
ComexPerú, Informe de calidad del gasto público en Salud (2019); Matus-López, M., Toledo, L.P., and Pedraza, C.C., “Evaluación del espacio fiscal para la salud en Perú Investigación original,” in Revista Panamericana de Salud Publica 40, no. 1 (2016).Google Scholar
Guerrero-Ojeda, G.A., “Gasto de Bolsillo en salud y riesgo de pobreza en hogares peruanos. Peru 2917,” Revista Salud & Vida Sipanense 7, no. 2 (2020).Google Scholar
Hernández-Vásquez, A., Vargas-Fernández, R., Magallanes-Quevedo, L., and Bendezu-Quispe, G., “Análisis del gasto de bolsillo en medicamentos e insumos en Perú en 2007 y 2016,” Medwave 20, no. 2 (2020): e7833; L. Magallanes Quevedo, Estudio comparativo del gasto de bolsillo en medicamentos e insumos en salud: Perú 2007-2016, Universidad Nacional Mayor de San Marcos (2019).CrossRefGoogle Scholar
Instituto Nacional de Estadística e Informatica (INEI), “Encuesta Nacional de Hogares,” 2019, available at <https://www.datosabiertos.gob.pe/dataset/encuesta-nacional-de-hogares-enaho-2019-instituto-nacional-de-estad%C3%ADstica-e-inform%C3%A1tica-inei> (last visited October 2, 2023).+(last+visited+October+2,+2023).>Google Scholar
Id. Google Scholar
Id. Google Scholar
Guerrero-Ojeda, G.A., “Gasto de Bolsillo en Salud y Riesgo de Pobreza en Hgares Peruanos: Peru 2017,” Salud & Vida Sipanense, 7 no. 2 (2020): 27–40.CrossRefGoogle Scholar
INEI, supra note 31.Google Scholar
Id. Google Scholar
Id. Google Scholar
Id. Google Scholar
L. García and C. Rojas, “Determinantes del Gasto del Bolsillo en el Perú, Documento de trabajo 500,” Departamento de Economía, Pontificia Universidad Católica del Perú (PUCP), 2021.Google Scholar
D. Proaño Falconi and E. Bernabé, 2018. “Determinants of Catastrophic Healthcare Expenditure in Peru,” International Journal of Health Economics and Management (May 9, 2018).Google Scholar
Tenorio‑Mucha, et al. (2022), “Using Government Data to Understand the Use and Availability of Medicines for Hypertension and Diabetes: Lessons from Peru,” Journal of Pharmaceutical Policy and Practic 5, no. 1 (2022): 86.CrossRefGoogle Scholar
Instituto Nacional de Estadística e Informática (INEI), “Encuesta Nacional de Hogares, 2019,” <https://www.datosabiertos.gob.pe/dataset/encuesta-nacional-de-hogares-enaho-2019-instituto-nacional-de-estad%C3%ADstica-e-inform%C3%A1tica-inei> (last visited October 2, 2023).+(last+visited+October+2,+2023).>Google Scholar
Brazilian Institute of Geography and Statistics — IBGE, Contas Satélite de Saúde 2010-2019, Serie Contas Nacionais, # 87 ed., 2022, available at <https://biblioteca.ibge.gov.br/visualizacao/livros/liv101928_informativo.pdf> (last visited September 1, 2023).+(last+visited+September+1,+2023).>Google Scholar
Garcia, L.P., Sant’Anna, A.C., Magalhães, L.C., Santana de Freitas, L.R.S, and Aurea, A.P., “Gastos das famílias brasileiras com medicamentos segundo a renda familiar: análise da Pesquisa de Orçamentos Familiares de 2002-2003 e de 2008-2009,” in Cadernos de Saúde Pública, Rio de Janeiro 29, no. 8 (2013): 1605–1616; T. Menezes, B. Campolina, F.G. Silveira, L.M. Servo, and S.F. Piola, “Capítulo 12: O Gasto e a Demanda das Famílias em Saúde: Uma análise a partir da POF 2002-2003,” in Gasto e Consumo das Famílias Brasileiras Contemporâneas, ed. IPEA, Brasília (DF), 2006.Google Scholar
Domingues, E.P., Andrade, M.V, Chein, F., Santiago, F.S., Perobelli, F.S., and Possa da Motta, G., “Uma análise dos impactos econômicos e setoriais do Programa Farmácia Popular do Brasil,” Pesquisa e Planejamento Econômico 45, no. 3 (2015).Google Scholar
IBGE, National Health Survey PNS, “Pesquisa Nacional de Saúde 2013,” concepts, methodology and microdata for the PNS2013 and PNS 2019, available at <https://www.ibge.gov.br/estatisticas/sociais/saude/29540-2013-pesquisa-nacional-de-saude.html?edicao=9177&t=o-que-e> (last visited October 2, 2023).+(last+visited+October+2,+2023).>Google Scholar
Id. Google Scholar
A.C.S. Correia, I.V.S. Geracy, M.S.D. Durães, and R.L. Giaocomin, “Desoneração de Medicamentos, Boletim Mensal sobre Subsídios da União,” Edição 14, Dezembro 2019, Ministério da Economia, Secretaria Especial da Fazenda, Brasília (2019).Google Scholar
IBGE, Pesquisa de Orçamentos Familiares 2017-2018: Perfil das Despesas no Brasil: Indicadores Selecionados (2020), ed. IBGE, Rio de Janeiro, 2020.Google Scholar
To calculate the budgetary expenses of the SUS expressed above we included the expenses related to the PFPB. All figures are expressed in US$ of 2018.Google Scholar
According to Viera (2018), federal pharmaceutical spending cover about 80 percent of the total public expenditures on pharmaceuticals in the country, given that 20 percent of these spendings are attributed to states and municipalities. F.S. Vieira, “Evolução do Gasto com Medicamentos do Sistema Único de Saúde no Período de 2010 a 2016,” Texto Para a Discussão 2356, Ed. IPEA, Rio de Janeiro, 2018.Google Scholar
The supply of medicines in the SUS, as defined by the PNAF, is structured into three components: (Basic, Strategic and Specialized). The Basic Component gathers expenses with transfers to states and municipalities acquire basic care medicines and medicines from the Women’s Health Program. The Specialized Component is responsible for expenses with high-cost medicines aimed at of high complexity and transfers for the municipal acquisition of medicines, and the Strategic Component is focused on medicines for diseases and conditions of marked epidemiological importance, with an endemic profile, neglected and of great socioeconomic impact.Google Scholar
Brazilian Institute of Geography and Statistics — IBGE, Contas Satélite de Saúde 2010-2019, Serie Contas Nacionais, # 87 ed., 2022, available at <https://biblioteca.ibge.gov.br/visualizacao/livros/liv101928_informativo.pdf> (last visited September 1, 2023).+(last+visited+September+1,+2023).>Google Scholar
IBGE, “PNS — Pesquisa Nacional de Saúde 2019,” available at <https://ibge.gov.br/en/statistics/social/health/16840-national-survey-of-health.html> (last visited September 1, 2023).+(last+visited+September+1,+2023).>Google Scholar
See Correia et al., supra note 47.Google Scholar
Boing, A.C., Andrade, F.B., Bertoldi, A.D., Peres, K.G.A., Massuda, A., and Boing, A.F., “Prevalências e desigualdades no acesso aos medicamentos por usuários do SistemaÚnico de Saúde no Brasil entre 2013 e 2019 ,” Cadernos de Saúde Pública 38, no. 6 (2022): e00114721.Google Scholar
See supra note 52.Google Scholar
IBGE, “POF — Pesquisa de Orçamentos Familiares 2002/2003,” available at <https://ibge.gov.br/estatisticas/sociais/justica-e-seguranca/19877-2002-2003.html> (last visited September 1, 2023); IBGE, “POF — Pesquisa de Orçamentos Familiares 2017/2018,” available at <https://www.ibge.gov.br/estatisticas/sociais/saude/24786-pesquisa-de-orcamentos-familiares-2.html> (last visited September 1, 2023).+(last+visited+September+1,+2023);+IBGE,+“POF+—+Pesquisa+de+Orçamentos+Familiares+2017/2018,”+available+at++(last+visited+September+1,+2023).>Google Scholar
Id.Google Scholar
IBGE, “Pesquisa de Orçamentos Familiares 2017-2018: Perfil das Despesas no Brasil: Indicadores Selecionados,” ed. IBGE (2020).Google Scholar
The Gini Index used in this work is based on the calculation of inequality according to population intervals. It is defined by the formula where G is the Gini Index, X is the accumulated percentage of the population and Y is the corresponding accumulated percentage of the income, expense of other variable where the concentration measure is applied, in the same population intervals. This index could range from 0 to -1 or 1, where 0 is maximum equity and -1 or 1 represents maximum inequity.Google Scholar
The Kakwani Index (K) is given by the difference between the Gini Index for Household Income (GI) and the Gini Index for Household Health Expenditures (GS), so that: K=GI-GS. If K is positive (GI>GS), health expenses (or drug expenses in the case of this paper) are contributing to improve the general distribution of family income. Similarly, if K is negative (GI<GS), it can be inferred that public health policies are not contributing to equity in income distribution.GS),+health+expenses+(or+drug+expenses+in+the+case+of+this+paper)+are+contributing+to+improve+the+general+distribution+of+family+income.+Similarly,+if+K+is+negative+(GIGoogle Scholar
The Gini coefficients for available household income are lower than those for total household gross income, since available income does not include direct taxes, fees, and other payments to the government that are, in general, progressive.Google Scholar
IBGE, “Pesquisa de Orçamentos Familiares, 2020-2003 and 2017-2018,” ed. IBGE, Rio de Janeiro.Google Scholar
Instituto Nacional de Estadísticas de Costa Rica (INEC), Income and Expenditure National Survey (ENIG) 2018.Google Scholar
H.A. Chamizo García, et al., “Inequidades socioespaciales en el acceso a los medicamentos en Costa Rica: las contradicciones de un modelo de atención solidario,” Población y Salud en Mesoamérica 8, no. 1 (2022).Google Scholar
Id. Google Scholar
Id.Google Scholar
Instituto Nacional de Estadísticas de Costa Rica (INEC), Income and Expenditure National Survey (ENIG) 2018.Google Scholar
Instituto Nacional de Estadísticas de Costa Rica (INEC), Income and Expenditure National Survey (ENIG) 2018.Google Scholar
Id. Google Scholar